- Trials with a EudraCT protocol (179)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
179 result(s) found for: Behavioral Disorder.
Displaying page 1 of 9.
EudraCT Number: 2015-004444-19 | Sponsor Protocol Number: CRIT124D2201 | Start Date*: 2016-04-05 | |||||||||||
Sponsor Name:Novartis Pharmaceutical corporation | |||||||||||||
Full Title: An open-label, behavioral-treatment-controlled evaluation of the effects of extended release methylphenidate (Ritalin® LA) on the frequency of cytogenetic abnormalities in children 6 - 12 years of ... | |||||||||||||
Medical condition: To determine whether the administration of extended-release methylphenidate in treatment-naïve children with ADHD affects the frequency of chromosomal abnormalities. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012261-61 | Sponsor Protocol Number: 2009-4-CC | Start Date*: 2009-08-20 | ||||||||||||||||
Sponsor Name:Academic Medical Center | ||||||||||||||||||
Full Title: Why methylphenidate is not successful in cocaine-dependent ADHD patients: a SPECT study comparing DAT before and after methylphenidate treatment in ADHD patients with and without cocaine dependence | ||||||||||||||||||
Medical condition: ADHD with and without substance use disorder (SUD) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001560-35 | Sponsor Protocol Number: 2358 | Start Date*: 2016-04-07 |
Sponsor Name:Brain Center Rudolf Magnus, University Medical Center Utrecht, Department of Psychiatry, Utrecht , the Netherlands | ||
Full Title: Bumetanide in Autism Medication and BIomarker study | ||
Medical condition: Autism Spectrum Disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000586-45 | Sponsor Protocol Number: S56327 | Start Date*: 2014-05-08 | |||||||||||
Sponsor Name:KU Leuven | |||||||||||||
Full Title: Oxytocin-based pharmacotherapy for Autism Spectrum Disorders: Investigating the neural and behavioral effects of a promising intervention approach | |||||||||||||
Medical condition: Young male adults with Autism Spectrum Disorders (18-30 years) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005177-23 | Sponsor Protocol Number: N01395 | Start Date*: 2012-09-27 | |||||||||||
Sponsor Name:UCB Pharma SA | |||||||||||||
Full Title: An Open-Label, Multicenter, Single-Arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects with Epilepsy Switching from Levetiracetam to Brivaracetam due to Nonpsych... | |||||||||||||
Medical condition: Nonpyschotic Behavioural Side Effects in Subjects With Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004073-10 | Sponsor Protocol Number: AAAB01 | Start Date*: 2006-12-21 | |||||||||||
Sponsor Name:University of Giessen | |||||||||||||
Full Title: Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD | |||||||||||||
Medical condition: Adult Attention Deficit Hyperactivity Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005111-40 | Sponsor Protocol Number: CN138-178 | Start Date*: 2017-04-07 |
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc | ||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Flexible- Dosed Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents with Autistic Disorder | ||
Medical condition: Autistic Disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2009-010276-16 | Sponsor Protocol Number: F1D-MC-HGMX | Start Date*: 2009-11-19 | ||||||||||||||||
Sponsor Name:Eli Lilly | ||||||||||||||||||
Full Title: A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia | ||||||||||||||||||
Medical condition: Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002111-82 | Sponsor Protocol Number: 42603ATT3013 | Start Date*: 2007-10-24 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i... | |||||||||||||
Medical condition: Attention Deficit-Hyperactivity Disorder (ADHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) SE (Completed) NL (Completed) DK (Completed) FI (Completed) BE (Completed) GB (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022511-18 | Sponsor Protocol Number: X04 | Start Date*: 2011-04-05 | |||||||||||
Sponsor Name:Albert-Ludwig University Freiburg, Laboratory for Biological and Personality Psychology | |||||||||||||
Full Title: Behavioral effects and neural correlates of oxytocin on social attention [Verhaltenseffekte und neuronales Korrelat von Oxytocin im Kontext sozialer Aufmerksamkeit] | |||||||||||||
Medical condition: subjects with autism spectrum disorder and neurotypical controls | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001042-28 | Sponsor Protocol Number: CONCERTAATT4080 | Start Date*: 2015-04-24 | |||||||||||
Sponsor Name:Ortho-McNeil Janssen Scientific Affairs LLC | |||||||||||||
Full Title: Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children with ADHD (The ABC Study) | |||||||||||||
Medical condition: Attention Deficit Hyperactivity Disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001081-26 | Sponsor Protocol Number: CONCERTAATT4069 | Start Date*: 2015-04-24 | |||||||||||
Sponsor Name:Ortho-McNeil Janssen Scientific Affairs LLC | |||||||||||||
Full Title: The ABC Study: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral, and Cognitive Effects of CONCERTA on Older Children with ADHD | |||||||||||||
Medical condition: Attention Deficit Hyperactivity Disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000211-80 | Sponsor Protocol Number: 18024 | Start Date*: 2019-08-26 | |||||||||||
Sponsor Name:Child and adolescent Psychiatry, South Jutland | |||||||||||||
Full Title: Melatonin – production and release in children and adolescents with ADHD and chronic sleep problems | |||||||||||||
Medical condition: Attention Deficit Hyperactivity Disorder and Sleep Problems | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000867-21 | Sponsor Protocol Number: NGAM-13 | Start Date*: 2021-08-16 |
Sponsor Name:Octapharma Pharmazeutika Produktionsges.m.b.H. | ||
Full Title: A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome | ||
Medical condition: Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a research diagnosis given to patients who have an abrupt, dramatic onset of neuropsychiatric symptoms including obsessions/compulsio... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000227-25 | Sponsor Protocol Number: CRIT124DDE03 | Start Date*: 2008-10-15 | |||||||||||
Sponsor Name:Dept. Child & Adolescent Psychiatrie | |||||||||||||
Full Title: A single-center, single-blind, randomized, oral dose cross-over study in prepuberal boys with ADHD to investigate efficacy and bioequivalence of 20 mg Ritalin LA® compared to 20 mg Medikinet® retar... | |||||||||||||
Medical condition: Patients having a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) of any type according to DSM-IV criteria, as established by history, psychiatric examination and a structured diagnost... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006804-12 | Sponsor Protocol Number: ucb L059 | Start Date*: 2007-03-15 | |||||||||||||||||||||
Sponsor Name:ErasmusMedical Center-Sophia | |||||||||||||||||||||||
Full Title: Levetiracetam (Keppra®) in neonates | |||||||||||||||||||||||
Medical condition: epileptic seizures in neonates admitted to the intensive care unit | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023654-37 | Sponsor Protocol Number: 34509 | Start Date*: 2011-03-24 | ||||||||||||||||
Sponsor Name:Academic Medical Center | ||||||||||||||||||
Full Title: Effects of methylphenidate on the development of the dopaminergic system in the brain | ||||||||||||||||||
Medical condition: This project investigates whether the effects of methylfenidate on the outgrowth of the dopaminergic system are dependent on age. In a 16 week multicenter, dounle-blind, placebo controlled trial wi... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002875-81 | Sponsor Protocol Number: NL58621.041.16 | Start Date*: 2016-10-19 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Bumetanide for the Autism Spectrum Clinical Effectiveness Trial | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Epilepsy | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005346-37 | Sponsor Protocol Number: F1D-MC-HGMR | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Maintenance of Effect Study of Olanzapine in the Treatment of Disruptive Behavioral Symptoms in Children and Adolescents with Pervasive Developmental ... | |||||||||||||
Medical condition: children and adolescents with disruptive behavioral symptoms associated with Pervasive Developmental Disorders (PDD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000210-19 | Sponsor Protocol Number: CRIT124D2302E1 | Start Date*: 2011-06-10 | |||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||||||||||||
Full Title: A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-on... | |||||||||||||||||||||||
Medical condition: Adult patients with childhood-onset Attention Deficit Hyperactivity Disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Completed) BE (Completed) DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.